Celestica, Inc (CLS) concluded trading on Wednesday at a closing price of $88.19, with 4.98 million shares of worth about $439.0 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 52.53% during that period and on April 23, 2025 the price saw a gain of about 6.55%. Currently the company’s common shares owned by public are about 116.36M shares, out of which, 115.36M shares are available for trading.
Stock saw a price change of 6.81% in past 5 days and over the past one month there was a price change of -11.79%. Year-to-date (YTD), CLS shares are showing a performance of -4.45% which increased to 116.52% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $40.25 but also hit the highest price of $144.27 during that period. The average intraday trading volume for Celestica, Inc shares is 5.50 million. The stock is currently trading 11.15% above its 20-day simple moving average (SMA20), while that difference is down -6.08% for SMA50 and it goes to 12.34% higher than SMA200.
Celestica, Inc (NYSE: CLS) currently have 116.36M outstanding shares and institutions hold larger chunk of about 77.25% of that.
The stock has a current market capitalization of $10.23B and its 3Y-monthly beta is at 1.61. PE ratio of stock for trailing 12 months is 24.42, while it has posted earnings per share of $3.61 in the same period. Its PEG reads 1.12 and has Quick Ratio of 0.91 while making debt-to-equity ratio of 0.42. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CLS, volatility over the week remained 6.85% while standing at 9.47% over the month.
Stock’s fiscal year EPS is expected to rise by 24.17% while it is estimated to increase by 21.11% in next year. EPS is likely to shrink at an annualized rate of 21.76% for next 5-years, compared to annual growth of 46.52% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on February 21, 2025 offering an Overweight rating for the stock and assigned a target price of $166 to it. Coverage by Stifel stated Celestica, Inc (CLS) stock as a Buy in their note to investors on February 04, 2025, suggesting a price target of $140 for the stock. On January 31, 2025, CIBC Upgrade their recommendations, while on November 22, 2024, UBS Initiated their ratings for the stock with a price target of $95. Stock get an Overweight rating from Barclays on November 05, 2024.
